Envestnet Asset Management »

Allogene Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $44k 16k 2.80
2024-06-30 $33k 14k 2.33
2024-03-31 $55k 12k 4.47
2021-09-30 $390k 15k 25.67
2021-06-30 $398k 15k 26.09
2021-03-31 $536k 15k 35.29

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Allogene Therapeutics

Tpg Gp A
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
PRIMECAP Management Company
Citadel Advisors
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Investments
Wildcat Capital Management

View all funds holding Allogene Therapeutics